M. K. Proteins Limited
NSE MKPL.NS
M. K. Proteins Limited Capital Expenditure for the year ending March 31, 2024: USD -707.74 K
M. K. Proteins Limited Capital Expenditure is USD -707.74 K for the year ending March 31, 2024, a -80,632.22% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).
-
M. K. Proteins Limited Capital Expenditure for the year ending March 31, 2023 was USD -876.66, a 99.58% change year over year.
-
M. K. Proteins Limited Capital Expenditure for the year ending March 31, 2022 was USD -207.06 K, a -485.28% change year over year.
-
M. K. Proteins Limited Capital Expenditure for the year ending March 31, 2021 was USD -35.38 K, a -737.03% change year over year.
-
M. K. Proteins Limited Capital Expenditure for the year ending March 31, 2020 was USD -4.23 K, a 81.53% change year over year.
Key data
| Date | Capital Expenditure | Free Cash Flow | Depreciation And Amortization | Deferred Income Tax |
|---|
Market news
Loading...
NSE: MKPL.NS
| CEO | Mr. Vinod Kumar |
| IPO Date | July 27, 2017 |
| Location | India |
| Headquarters | Naraingarh Road |
| Employees | 48 |
| Sector | Energy |
| Industries | |
Description
M. K. Proteins Limited manufactures and trades in vegetable refined oil and by-products. The company offers refine rice bran, sunflower, cotton seed, soya bean, palm, canola, and rice bran bleached oils. It also provides by-products, such as rice bran fatty acid oils, rice bran waxes, gums, and spent earth; and imports and trades in edible and non-edible oils. The company was incorporated in 2012 and is based in Ambala, India.
Key trends
Past 5 years
StockViz Staff
January 16, 2025
Any question? Send us an email